These results demonstrate that Idh2R140Q or Idh2R172K mutant alleles observed in human cancers can act as potent oncogenes in mice, but this action is performed in a cooperative manner together with Flt3-ITD and NrasG12D mutations to promote AML. The gene discussed is FLT3; the disease is acute myeloid leukemia.